CRISIL has confirmed Pokarna's long-term and short-term ratings as 'CRISIL A/Stable', indicating a stable outlook. This rating applies to both the parent company and its subsidiary, Pokarna Engineered Stone Ltd, for a total loan facility of approximately 6.51 billion INR.

Pokarna Limited will finalize and announce their audited financial results for the year on May 28, 2026. The board is also expected to make a dividend recommendation during this meeting. Investors should note that trading activity in the company's shares will be suspended for 48 hours following the results announcement.

Pokarna Limited has been accused of misusing mining permits by the Andhra Pradesh Mines Department, leading to a demand of INR 33.4 billion. The company intends to appeal the decision, with no immediate financial implications expected due to this dispute.

Pokarna Ltd has agreed to continue Gautam Jain as Chairman and Managing Director, along with Rahul Jain as Managing Director, for a period of five years, starting from May and July 2026 (subject to shareholder approval).

Kush Bohra suggests investing in Aurobindo Pharma, Nava, and Pokarna for quick profits due to their robust technical indicators. He sets targets at Rs 1415/1480 for Aurobindo, Rs 628/645 for Nava, and Rs 945/965 for Pokarna. It's important to monitor these investments closely with stop-loss levels in place.